Horizon Pharma (HZNP) Tops Q2 EPS by 7c

Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $172.8 million versus the consensus estimate of $156.41 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Creatd files Form S-1 and reports Q1 2026 financial results
• Goldman "broadly" raises estimates for LTL and truckload stocks